This is why retatrutide shows extraordinary results in liver fat reduction , with clinical data showing up to 82% decreases in liver fat content, a result no dual agonist has matched
Patients treated with JANUVIA exhibited a significant mean decrease from baseline in body weight compared to a significant weight gain in patients administered glipizide (-1.5 kg vs +1.1 kg)
Jones, Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Not patches
Since LC is still used by the athletes [9, 10], the aim of this systematic review is to evaluate the effect of prolonged LC supplementation on metabolism/metabolic changes in healthy human subjects
Newer triple agonists Retatrutide , the investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, showed higher overall GI event rates in Phase 2 trials at its highest doses